SCHEMBL7143669

SCHEMBL7143669

NC(=O)CC[C@H](NC(=O)c1ccc(CCc2c[nH]c3nc(N)[nH]c(=O)c23)cc1)C(=O)[O-].NC(=O)CC[C@H](NC(=O)c1ccc(CCc2c[nH]c3nc(N)[nH]c(=O)c23)cc1)C(=O)[O-].[Na+].[Na+]

nearest known ligand 0.89

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TYMS known ✓ P04818 9/20 0.89
GART known ✓ P22102 7/20 0.74
DHFR known ✓ P00374 4/20 0.74
FOLR1 P15328 7/20 0.74
SLC46A1 Q96NT5 7/20 0.74
SLC19A1 P41440 6/20 0.74
FOLR2 P14207 3/20 0.74
ATIC P31939 2/20 0.74
SHMT1 P34896 1/20 0.74
FRK P42685 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pemetrexed SCHEMBL6076020 0.94 TYMS (1.00) TYMSFOLR1SLC46A1GARTSLC19A1
Pemetrexed SCHEMBL1933385 0.94 TYMS (1.00) TYMSFOLR1SLC46A1GARTSLC19A1
Pemetrexed SCHEMBL6075234 0.93 TYMS (0.98) TYMSFOLR1SLC46A1GARTSLC19A1
Pemetrexed SCHEMBL6075227 0.93 TYMS (0.98) TYMSFOLR1SLC46A1GARTSLC19A1
SCHEMBL7144593 0.91 GART (0.88) TYMSFOLR1SLC46A1GARTSLC19A1
SCHEMBL18689788 0.86 GART (0.88) TYMSFOLR1SLC46A1GARTSLC19A1
Pemetrexed SCHEMBL209720 0.85 GART (1.00) TYMSFOLR1SLC46A1GARTSLC19A1
Pemetrexed SCHEMBL5959741 0.85 GART (1.00) TYMSFOLR1SLC46A1GARTSLC19A1
Pemetrexed SCHEMBL7144918 0.85 GART (1.00) TYMSFOLR1SLC46A1GARTSLC19A1
SCHEMBL13915417 0.84 TYMS (0.76) TYMSFOLR1SLC46A1GARTSLC19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1259513-B1 A NOVEL CRYSTALLINE FORM OF N- 4- 2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO 2,3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR LILLY CO ELI (US) 2003-09-10 EP claimed